214 related articles for article (PubMed ID: 23339402)
1. Evolution of an amino acid based prodrug approach: stay tuned.
Krylov IS; Kashemirov BA; Hilfinger JM; McKenna CE
Mol Pharm; 2013 Feb; 10(2):445-58. PubMed ID: 23339402
[TBL] [Abstract][Full Text] [Related]
2. N(4)-Acyl derivatives as lipophilic prodrugs of cidofovir and its 5-azacytosine analogue, (S)-HPMP-5-azaC: chemistry and antiviral activity.
Krečmerová M; Pohl R; Masojídková M; Balzarini J; Snoeck R; Andrei G
Bioorg Med Chem; 2014 May; 22(10):2896-906. PubMed ID: 24731540
[TBL] [Abstract][Full Text] [Related]
3. Amino Acid Ester Prodrugs of Nucleoside and Nucleotide Antivirals.
Krecmerova M
Mini Rev Med Chem; 2017; 17(10):818-833. PubMed ID: 28215138
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of peptidomimetic conjugates of cyclic nucleoside phosphonates.
Serpi M; Krylov IS; Zakharova VM; McKenna CE
Curr Protoc Nucleic Acid Chem; 2010 Dec; Chapter 15():Unit15.4. PubMed ID: 21154529
[TBL] [Abstract][Full Text] [Related]
5. Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.
Hostetler KY
Antiviral Res; 2009 May; 82(2):A84-98. PubMed ID: 19425198
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication.
Keith KA; Hitchcock MJ; Lee WA; Holý A; Kern ER
Antimicrob Agents Chemother; 2003 Jul; 47(7):2193-8. PubMed ID: 12821467
[TBL] [Abstract][Full Text] [Related]
7. Structure of cyclic nucleoside phosphonate ester prodrugs: an inquiry.
Krylov IS; Zakharova VM; Serpi M; Haiges R; Kashemirov BA; McKenna CE
J Org Chem; 2012 Jan; 77(1):684-9. PubMed ID: 22126969
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine-based 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine and -adenine ((S)-HPMPC and (S)-HPMPA) prodrugs: synthesis, stability, antiviral activity, and in vivo transport studies.
Zakharova VM; Serpi M; Krylov IS; Peterson LW; Breitenbach JM; Borysko KZ; Drach JC; Collins M; Hilfinger JM; Kashemirov BA; McKenna CE
J Med Chem; 2011 Aug; 54(16):5680-93. PubMed ID: 21812420
[TBL] [Abstract][Full Text] [Related]
9. Serine peptide phosphoester prodrugs of cyclic cidofovir: synthesis, transport, and antiviral activity.
Eriksson U; Peterson LW; Kashemirov BA; Hilfinger JM; Drach JC; Borysko KZ; Breitenbach JM; Kim JS; Mitchell S; Kijek P; McKenna CE
Mol Pharm; 2008; 5(4):598-609. PubMed ID: 18481868
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the in vitro growth of Plasmodium falciparum by acyclic nucleoside phosphonates.
Smeijsters LJ; Franssen FF; Naesens L; de Vries E; Holý A; Balzarini J; de Clercq E; Overdulve JP
Int J Antimicrob Agents; 1999 Jun; 12(1):53-61. PubMed ID: 10389648
[TBL] [Abstract][Full Text] [Related]
11. New prodrugs of Adefovir and Cidofovir.
Tichý T; Andrei G; Dračínský M; Holý A; Balzarini J; Snoeck R; Krečmerová M
Bioorg Med Chem; 2011 Jun; 19(11):3527-39. PubMed ID: 21565516
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and (S)-HPMPA.
Dal Pozzo F; Andrei G; Lebeau I; Beadle JR; Hostetler KY; De Clercq E; Snoeck R
Antiviral Res; 2007 Jul; 75(1):52-7. PubMed ID: 17184854
[TBL] [Abstract][Full Text] [Related]
13. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.
Hartline CB; Gustin KM; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
J Infect Dis; 2005 Feb; 191(3):396-9. PubMed ID: 15633099
[TBL] [Abstract][Full Text] [Related]
14. Serine side chain-linked peptidomimetic conjugates of cyclic HPMPC and HPMPA: synthesis and interaction with hPEPT1.
Peterson LW; Sala-Rabanal M; Krylov IS; Serpi M; Kashemirov BA; McKenna CE
Mol Pharm; 2010 Dec; 7(6):2349-61. PubMed ID: 20929265
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cells.
Coen N; Duraffour S; Naesens L; Krecmerová M; Van den Oord J; Snoeck R; Andrei G
J Virol; 2013 Nov; 87(22):12422-32. PubMed ID: 24027315
[TBL] [Abstract][Full Text] [Related]
16. Aryl ester prodrugs of cyclic HPMPC. I: Physicochemical characterization and in vitro biological stability.
Oliyai R; Shaw JP; Sueoka-Lennen CM; Cundy KC; Arimilli MN; Jones RJ; Lee WA
Pharm Res; 1999 Nov; 16(11):1687-93. PubMed ID: 10571273
[TBL] [Abstract][Full Text] [Related]
17. Oral USC-093, a novel homoserinamide analogue of the tyrosinamide (S)-HPMPA prodrug USC-087 has decreased nephrotoxicity while maintaining antiviral efficacy against human adenovirus infection of Syrian hamsters.
Tollefson AE; Riemann SB; Ying B; Spencer JF; Overhulse JM; Kashemirov BA; Wold WSM; McKenna CE; Toth K
Antiviral Res; 2024 Feb; 222():105799. PubMed ID: 38190973
[TBL] [Abstract][Full Text] [Related]
18. Enhanced chemical stability of the intracellular prodrug, 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine, relative to its parent compound, cidofovir.
Oliyai R; Lee WA; Visor GC; Yuan LC
Int J Pharm; 1999 Mar; 179(2):257-65. PubMed ID: 10053218
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
[TBL] [Abstract][Full Text] [Related]
20. Some novel aminopropyl nucleoside phosphonates.
Zhou D; Lagoja IM; Van Aerschot A
Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):563-6. PubMed ID: 18066856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
